183 related articles for article (PubMed ID: 23065255)
1. Expression of survivin and patients survival in non-small cell lung cancer: a meta-analysis of the published studies.
Huang LN; Wang DS; Chen YQ; Zhao CL; Gong BL; Jiang AB; Jia W; Hu FD
Mol Biol Rep; 2013 Feb; 40(2):917-24. PubMed ID: 23065255
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysis.
Zhang LQ; Wang J; Jiang F; Xu L; Liu FY; Yin R
PLoS One; 2012; 7(3):e34100. PubMed ID: 22457815
[TBL] [Abstract][Full Text] [Related]
3. The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures.
Fan J; Wang L; Jiang GN; He WX; Ding JA
Lung Cancer; 2008 Jul; 61(1):91-6. PubMed ID: 18192073
[TBL] [Abstract][Full Text] [Related]
4. Survivin expression impacts prognostically on NSCLC but not SCLC.
Rosato A; Menin C; Boldrin D; Dalla Santa S; Bonaldi L; Scaini MC; Del Bianco P; Zardo D; Fassan M; Cappellesso R; Fassina A
Lung Cancer; 2013 Feb; 79(2):180-6. PubMed ID: 23218791
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis: prognostic value of survivin in patients with hepatocellular carcinoma.
Liu JL; Zhang XJ; Zhang Z; Zhang AH; Wang W; Dong JH
PLoS One; 2013; 8(12):e83350. PubMed ID: 24386184
[TBL] [Abstract][Full Text] [Related]
6. Nuclear survivin expression is associated with a poor prognosis in Caucasian non-small cell lung cancer patients.
Xie YL; An L; Jiang H; Wang J
Clin Chim Acta; 2012 Dec; 414():41-3. PubMed ID: 22981350
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer.
Liang Y; Guo S; Zhou Q
Tumour Biol; 2014 Apr; 35(4):3717-24. PubMed ID: 24338766
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis.
Lv S; Turlova E; Zhao S; Kang H; Han M; Sun HS
Tumour Biol; 2014 Feb; 35(2):1565-74. PubMed ID: 24101190
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.
Cho HJ; Kim HR; Park YS; Kim YH; Kim DK; Park SI
Surg Oncol; 2015 Dec; 24(4):329-34. PubMed ID: 26690822
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of survivin expression in breast cancer patients: a meta-analysis.
Song J; Su H; Zhou YY; Guo LL
Tumour Biol; 2013 Aug; 34(4):2053-62. PubMed ID: 23690235
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
Tan Z; Shen W
Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis for cyclin E in lung cancer survival.
Huang LN; Wang DS; Chen YQ; Li W; Hu FD; Gong BL; Zhao CL; Jia W
Clin Chim Acta; 2012 Apr; 413(7-8):663-8. PubMed ID: 22244930
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer.
Peng WJ; Zhang JQ; Wang BX; Pan HF; Lu MM; Wang J
Clin Chim Acta; 2012 Jul; 413(13-14):1121-6. PubMed ID: 22465234
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-mediated epigenetic targeting of Survivin significantly enhances the antitumor activity of paclitaxel against non-small cell lung cancer.
Wang S; Zhu L; Zuo W; Zeng Z; Huang L; Lin F; Lin R; Wang J; Lu J; Wang Q; Lin L; Dong H; Wu W; Zheng K; Cai J; Yang S; Ma Y; Ye S; Liu W; Yu Y; Tan J; Liu B
Oncotarget; 2016 Jun; 7(25):37693-37713. PubMed ID: 27177222
[TBL] [Abstract][Full Text] [Related]
15. Expression of Elf-1 and survivin in non-small cell lung cancer and their relationship to intratumoral microvessel density.
Yang DX; Li NE; Ma Y; Han YC; Shi Y
Chin J Cancer; 2010 Apr; 29(4):396-402. PubMed ID: 20346215
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of survivin and VEGF mRNA detection in the cell fraction of the peripheral blood in non-small cell lung cancer patients before and after surgery.
Tang XP; Li J; Yu LC; Chen YC; Shi SB; Zhu LR; Chen P
Lung Cancer; 2013 Aug; 81(2):273-9. PubMed ID: 23756092
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis.
Lou-Qian Z; Rong Y; Ming L; Xin Y; Feng J; Lin X
PLoS One; 2013; 8(1):e54970. PubMed ID: 23372805
[TBL] [Abstract][Full Text] [Related]
18. [Subcellular localization of survivin in non-small cell lung cancer].
He L; Hou M; Zhang J; Xu N; Chen P
Ai Zheng; 2009 Sep; 28(9):955-60. PubMed ID: 19728914
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysis.
Liu JL; Gao W; Kang QM; Zhang XJ; Yang SG
PLoS One; 2013; 8(8):e71930. PubMed ID: 23936532
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysis.
Jiang H; Zhao W; Shao W
Tumour Biol; 2014 Aug; 35(8):7383-9. PubMed ID: 24913707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
